首页> 外文OA文献 >Predictors of HBeAg seroconversion after long-term nucleos(t)ide analogues treatment for chronic hepatitis B: a multicenter study in real clinical setting

【2h】

Predictors of HBeAg seroconversion after long-term nucleos(t)ide analogues treatment for chronic hepatitis B: a multicenter study in real clinical setting

机译：长期核苷（酸）类似物治疗慢性乙型肝炎后HBeag血清学转换的预测因子：真实临床环境中的多中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Weiyan Yu; Yadong Wang; Chuan Shen; Ru Ji; Li Zhang; Xin Zhao; Miao Su; Ying Zhang; Wenyan He; Jianguo Cao; Yanshuang Hao; Shengpeng Chen; Caiyan Zhao;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Predictors of HBeAg seroconversion after long-term nucleos(t)ide analogues treatment for chronic hepatitis B: a multicenter study in real clinical setting [J] . Weiyan Yu, Li Zhang, Chuan Shen, Brazilian Journal of Infectious Diseases . 2017,第3期

机译：长期核苷酸（t）类似物治疗慢性乙型肝炎后HBeAg血清转化的预测因素：真实临床环境中的多中心研究
2. Change of HBsAg quantity and its relation with HBeAg seroconversion following 48 weeks pegylated-interferon-alpha treatment in HBeAg positive chronic hepatitis B patients after long term nucleos(t)ide analogue maintenance therapy (Roll Over trial) : Interim analysis at 48 weeks [J] . Woo Hyun Young, Heo Jeong, Tak Won Young, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：在长期核细胞核（T）IDE模拟维护治疗后48周阳性慢性乙型肝炎患者中48周PEGEND-Welloton-α治疗后48周的HBSAG血清转化的变化及其与HBEAG血清转化的关系
3. Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues [J] . Fan Rong, Sun Jian, Yuan Quan, Gut: Journal of the British Society of Gastroenterology . 2016,第2期

机译：仅基线定量乙型肝炎核心抗体滴度就可强烈预测接受聚乙二醇干扰素或核苷（核苷酸）类似物治疗的慢性乙型肝炎患者的HBeAg血清转化
4. Intelligent clinical decision supports for interferon treatment in chronic hepatitis C and B based on i-biopsy™ [C] . Floares, A.G. International Joint Conference on Neural Networks;IJCNN 2009 . 2009

机译：基于i-biopsy™的智能临床决策支持对慢性丙型和乙型肝炎的干扰素治疗
5. Incidence, Durability, and Clinical Outcomes of Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B [D] . Yip, Cheuk Fung. 2019

机译：慢性乙型肝炎患者乙型肝炎表面抗原血管疮的发病率，耐久性和临床结果
6. Original article: Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues [O] . Rong Fan, Jian Sun, Quan Yuan, -1

机译：原始文章：仅基线定量乙型肝炎核心抗体滴度就可以强烈预测接受聚乙二醇干扰素或核苷（核苷酸）类似物治疗的慢性乙型肝炎患者的HBeAg血清转化
7. HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis. [O] . Tongjing Xing, Hongtao Xu, Lin Cao, 2017

机译：HBeag血清转换HBeag阳性慢性乙型肝炎患者接受长期核（t）ide模拟治疗：系统评价和网络meta分析。

Predictors of HBeAg seroconversion after long-term nucleos(t)ide analogues treatment for chronic hepatitis B: a multicenter study in real clinical setting

著录项

引文网络

相似文献

相关主题

期刊订阅